Global Market Study on Irritable Bowel Syndrome Treatment: North America to Remain Leading Regional Market through 2031

Publish Date: Sep 2021

Report Code: PMR1747A

Publisher: Persistence Market Research

Download Report Overview

Single User License: $4900

Explore Our Services

Already a member? Login here.

Sample Report

Report Highlights

Irritable Bowel Syndrome Treatment Market - Scope of Report

The latest publication by Persistence Market Research on the global irritable bowel syndrome treatment market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.

The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for irritable bowel syndrome treatment products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the irritable bowel syndrome treatment market.

The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the Irritable Bowel Syndrome Treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the irritable bowel syndrome treatment market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the irritable bowel syndrome treatment market offers information divided into four important segments – drug type, indication, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Type

Fiber Supplements
Anti-Diarrheal
Anticholinergic and Antispasmodic
Antidepressants
Antibiotics
Alosetron
Lubiprostone
Linaclotide
NHE3

Indication

Irritable Bowel Syndrome with Constipation
Irritable Bowel Syndrome with Diarrhea
Irritable Bowel Syndrome with Alternating Constipation and Diarrhea

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies and Stores
Hypermarkets and Supermarkets

Region

North America
Latin America
Europe
East Asia
South Asia and Pacific
MEA

Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for irritable bowel syndrome treatment over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the irritable bowel syndrome treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the irritable bowel syndrome treatment market more accurate and reliable.

Table 1 : Global Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Type
Table 2 : Global Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 3 : Global Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 4 : Global Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 5 : North America Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Type
Table 6 : North America Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 7 : North America Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 8 : North America Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 9 : Latin America Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Type
Table 10 : Latin America Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 11 : Latin America Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 12 : Latin America Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 13 : Europe Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Type
Table 14 : Europe Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 15 : Europe Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 16 : Europe Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 17 : East Asia Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Type
Table 18 : East Asia Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 19 : East Asia Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 20 : East Asia Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 21 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Type
Table 22 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 23 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 24 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 25 : MEA Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Type
Table 26 : MEA Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 27 : MEA Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 28 : MEA Irritable Bowel Syndrome Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Figure 1 : Global Irritable Bowel Syndrome Treatment Market Historical Market Value (US$ Mn) Analysis, 2016-2020
Figure 2 : Global Irritable Bowel Syndrome Treatment Current and Future Market Value (US$ Mn), 2021-2031 & Y-o-Y Growth Trend Analysis
Figure 3 : Irritable Bowel Syndrome Treatment Market Absolute $ Opportunity, 2021–2031
Figure 4 : Global Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 5 : Global Irritable Bowel Syndrome Treatment Market Y-o-Y Growth (%) By Drug Type, 2021-2031
Figure 6 : Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Type
Figure 7 : Global Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 8 : Global Irritable Bowel Syndrome Treatment Market Y-o-Y Growth (%) By Indication, 2021-2031
Figure 9 : Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Indication
Figure 10 : Global Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 11 : Global Irritable Bowel Syndrome Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2021-2031
Figure 12 : Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 13 : Global Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Region, 2021 & 2031
Figure 14 : Global Irritable Bowel Syndrome Treatment Market Y-o-Y Growth (%) By Region, 2021-2031
Figure 15 : Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Region
Figure 16 : North America Irritable Bowel Syndrome Treatment Market Share, By Drug Type (2021)
Figure 17 : North America Irritable Bowel Syndrome Treatment Market Share, By Indication (2021)
Figure 18 : North America Irritable Bowel Syndrome Treatment Market Share, By Distribution Channel (2021)
Figure 19 : North America Irritable Bowel Syndrome Treatment Market Share, By Country (2021)
Figure 20 : North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016–2020
Figure 21 : North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 22 : North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
Figure 23 : North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Type
Figure 24 : North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Indication
Figure 25 : North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 26 : Latin America Irritable Bowel Syndrome Treatment Market Share, By Drug Type (2021)
Figure 27 : Latin America Irritable Bowel Syndrome Treatment Market Share, By Indication (2021)
Figure 28 : Latin America Irritable Bowel Syndrome Treatment Market Share, By Distribution Channel (2021)
Figure 29 : Latin America Irritable Bowel Syndrome Treatment Market Share, By Country (2021)
Figure 30 : Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016–2020
Figure 31 : Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 32 : Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
Figure 33 : Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Type
Figure 34 : Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Indication
Figure 35 : Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 36 : Europe Irritable Bowel Syndrome Treatment Market Share, By Drug Type (2021)
Figure 37 : Europe Irritable Bowel Syndrome Treatment Market Share, By Indication (2021)
Figure 38 : Europe Irritable Bowel Syndrome Treatment Market Share, By Distribution Channel (2021)
Figure 39 : Europe Irritable Bowel Syndrome Treatment Market Share, By Country (2021)
Figure 40 : Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016–2020
Figure 41 : Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 42 : Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
Figure 43 : Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Type
Figure 44 : Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Indication
Figure 45 : Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 46 : East Asia Irritable Bowel Syndrome Treatment Market Share, By Drug Type (2021)
Figure 47 : East Asia Irritable Bowel Syndrome Treatment Market Share, By Indication (2021)
Figure 48 : East Asia Irritable Bowel Syndrome Treatment Market Share, By Distribution Channel (2021)
Figure 49 : East Asia Irritable Bowel Syndrome Treatment Market Share, By Country (2021)
Figure 50 : East Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016–2020
Figure 51 : East Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 52 : East Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
Figure 53 : East Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Type
Figure 54 : East Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Indication
Figure 55 : East Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 56 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Share, By Drug Type (2021)
Figure 57 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Share, By Indication (2021)
Figure 58 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Share, By Distribution Channel (2021)
Figure 59 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Share, By Country (2021)
Figure 60 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016–2020
Figure 61 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 62 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
Figure 63 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Type
Figure 64 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Indication
Figure 65 : South Asia and Pacific Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 66 : MEA Irritable Bowel Syndrome Treatment Market Share, By Drug Type (2021)
Figure 67 : MEA Irritable Bowel Syndrome Treatment Market Share, By Indication (2021)
Figure 68 : MEA Irritable Bowel Syndrome Treatment Market Share, By Distribution Channel (2021)
Figure 69 : MEA Irritable Bowel Syndrome Treatment Market Share, By Country (2021)
Figure 70 : MEA Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016–2020
Figure 71 : MEA Irritable Bowel Syndrome Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 72 : MEA Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Country
Figure 73 : MEA Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Drug Type
Figure 74 : MEA Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Indication
Figure 75 : MEA Irritable Bowel Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 76 : U.S. Market Value Proportion Analysis
Figure 77 : Global Vs. U.S Growth Comparison
Figure 78 : U.S. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 79 : U.S. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 80 : U.S. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 81 : Canada Market Value Proportion Analysis
Figure 82 : Global Vs. Canada Growth Comparison
Figure 83 : Canada Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 84 : Canada Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 85 : Canada Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 86 : Brazil Market Value Proportion Analysis
Figure 87 : Global Vs. Brazil Growth Comparison
Figure 88 : Brazil Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 89 : Brazil Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 90 : Brazil Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 91 : Mexico Market Value Proportion Analysis
Figure 92 : Global Vs. Mexico Growth Comparison
Figure 93 : Mexico Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 94 : Mexico Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 95 : Mexico Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 96 : U.K. Market Value Proportion Analysis
Figure 97 : Global Vs. U.K. Growth Comparison
Figure 98 : Indonesia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031170
Figure 99 : U.K. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 100 : U.K. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 101 : U.K. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 102 : Germany Market Value Proportion Analysis
Figure 103 : Global Vs. Germany Growth Comparison
Figure 104 : Germany Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 105 : Germany Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 106 : Germany Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 107 : Italy Market Value Proportion Analysis
Figure 108 : Global Vs. Italy Growth Comparison
Figure 109 : Italy Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 110 : Italy Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 111 : Italy Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 112 : France Market Value Proportion Analysis
Figure 113 : Global Vs. France Growth Comparison
Figure 114 : France Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 115 : France Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 116 : France Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 117 : BENELUX Market Value Proportion Analysis
Figure 118 : Global Vs. BENELUX Growth Comparison
Figure 119 : BENELUX Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 120 : BENELUX Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 121 : BENELUX Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 122 : Spain Market Value Proportion Analysis
Figure 123 : Global Vs. Spain Growth Comparison
Figure 124 : Spain Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 125 : Spain Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 126 : Spain Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 127 : Russia Market Value Proportion Analysis
Figure 128 : Global Vs. Russia Growth Comparison
Figure 129 : Russia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 130 : Russia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 131 : Russia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 132 : China Market Value Proportion Analysis
Figure 133 : Global Vs. China Growth Comparison
Figure 134 : China Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 135 : China Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 136 : China Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 137 : Japan Market Value Proportion Analysis
Figure 138 : Global Vs. Japan Growth Comparison
Figure 139 : Japan Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 140 : Japan Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 141 : Japan Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 142 : South Korea Market Value Proportion Analysis
Figure 143 : Global Vs. South Korea Growth Comparison
Figure 144 : South Korea Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 145 : South Korea Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 146 : South Korea Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 147 : India Market Value Proportion Analysis
Figure 148 : Global Vs. India Growth Comparison
Figure 149 : India Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 150 : India Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 151 : India Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 152 : Thailand Market Value Proportion Analysis
Figure 153 : Global Vs. Thailand Growth Comparison
Figure 154 : Thailand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 155 : Thailand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 156 : Thailand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 157 : Malaysia Market Value Proportion Analysis
Figure 158 : Global Vs. Malaysia Growth Comparison
Figure 159 : Malaysia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 160 : Malaysia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 161 : Malaysia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 162 : ANZ Market Value Proportion Analysis
Figure 163 : Global Vs. ANZ Growth Comparison
Figure 164 : ANZ Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 165 : ANZ Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 166 : ANZ Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 167 : Indonesia Market Value Proportion Analysis
Figure 168 : Global Vs. Indonesia Growth Comparison
Figure 169 : Indonesia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 170 : Indonesia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 171 : Turkey Market Value Proportion Analysis
Figure 172 : Global Vs. Turkey Growth Comparison
Figure 173 : Turkey Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 174 : Turkey Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 175 : Turkey Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 176 : GCC Countries Market Value Proportion Analysis
Figure 177 : Global Vs. GCC Countries Growth Comparison
Figure 178 : GCC Countries Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 179 : GCC Countries Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 180 : GCC Countries Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 181 : South Africa Market Value Proportion Analysis
Figure 182 : Global Vs. South Africa Growth Comparison
Figure 183 : South Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Drug Type, 2021 & 2031
Figure 184 : South Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2021 & 2031
Figure 185 : South Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

FAQ

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More

Global Market Study on Irritable Bowel Syndrome Treatment: North America to Remain Leading Regional Market through 2031

Report Highlights

Related Reports

Recent Reports

Top Trending Reports

Become A Member

Custom Consulting

Scorecard

Innovation Spotlight